Pre-made Idarucizumab benchmark antibody ( Fab, anti-Dabigatran therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-261

Pre-Made Idarucizumab biosimilar, Fab: Anti-Dabigatran therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-261-1mg 1mg 3090
GMP-Bios-ab-261-10mg 10mg Inquiry
GMP-Bios-ab-261-100mg 100mg Inquiry
GMP-Bios-ab-261-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Pre-Made Idarucizumab biosimilar, Fab: Anti-Dabigatran therapeutic antibody
INN Name Idarucizumab
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusNFD
100% SI Structure4jn2:HL:BA/4jn1:HL
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2013
Year Recommended2014
CompaniesBoehringer Ingelheim
Conditions ApprovedBlood coagulation disorders
Conditions Activena
Conditions Discontinuedna
Development Techna